Microbix Biosystms (MBXBF) Financial Statements
Microbix Biosystms Financial Overview
Microbix Biosystms's market cap is currently $29.40M. The company's EPS TTM is $-0.04; its P/E ratio is -8.50; Microbix Biosystms has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.59M | $ 25.39M | $ 16.51M | $ 19.08M | $ 18.59M |
| Gross Profit | $ 9.85M | $ 15.39M | $ 7.48M | $ 11.12M | $ 11.04M |
| Operating Income | $ -1.58M | $ 3.91M | $ -2.74M | $ 2.69M | $ 4.84M |
| EBITDA | $ 428.23K | $ 6.21M | $ 1.96M | $ 3.73M | $ 5.66M |
| Net Income | $ -2.25M | $ 3.52M | $ -39.48K | $ 1.79M | $ 1.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.11M | $ 12.96M | $ 11.61M | $ 13.49M | $ 9.99M |
| Total Assets | $ 37.41M | $ 38.10M | $ 35.65M | $ 33.15M | $ 28.83M |
| Total Debt | $ 6.77M | $ 6.40M | $ 6.65M | $ 5.82M | $ 7.74M |
| Net Debt | $ -5.34M | $ -6.57M | $ -4.96M | $ -7.66M | $ -2.25M |
| Total Liabilities | $ 9.62M | $ 9.80M | $ 11.03M | $ 8.21M | $ 10.27M |
| Stockholders' Equity | $ 27.79M | $ 28.30M | $ 24.62M | $ 24.94M | $ 18.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -877.58K | $ 2.44M | $ -2.11M | $ 1.44M | $ 804.20K |
| Operating Cash Flow | $ -80.29K | $ 4.35M | $ -1.09M | $ 3.47M | $ 2.11M |
| Investing Cash Flow | $ -797.30K | $ -1.91M | $ -1.02M | $ -2.03M | $ -622.34K |
| Financing Cash Flow | $ 27.00K | $ -1.08M | $ 229.21K | $ 2.06M | $ 8.41M |
Currency in CAD
